Galera Therapeutics appoints chief medical officer

Sep. 01, 2022 7:20 AM ETGalera Therapeutics, Inc. (GRTX)By: Mary Christine Joy, SA News Editor

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research. Working on Computers, Analyzing Samples

gorodenkoff/iStock via Getty Images

  • Biopharmaceutical company Galera Therapeutics (NASDAQ:GRTX) appointed Eugene Kennedy chief medical officer.
  • Kennedy, who has served as chief medical officer at Innovative Cellular Therapeutics, will succeed Jon Holmlund.
  • Holmlund will retire at 2022-end, and in the interim, Kennedy and Holmlund will work together closely to ensure a smooth and successful transition.
  • Source: Press Release

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.